Share on LinkedInShare on LinkedIn

ARTICLE · 30 AUGUST 2021

COVID-19 Key EU Developments, Policy & Regulatory Update No. 58

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

European UnionCoronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission distributes first pre-financing under Recovery and Resilience Plans to 3 Member States
  • European Commission amends decision approving €7 billion in support to Air France in the context of the COVID-19 crisis
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • No noteworthy developments for this issue

Medicines and Medical Devices

  • European Commission confirms that on 31 January 2022, the Clinical Trials Regulation and becomes officially applicable and Clinical Trials Information System goes live

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from